<DOC>
	<DOCNO>NCT01599494</DOCNO>
	<brief_summary>This study , conduct India , recruit woman participant age 18 42 , indication control ovarian stimulation ( COS ) , yet undergone in-vitro fertilization and/or intracytoplasmic sperm injection ( IVF/ICSI ) . The study design compare difference oocyte ( immature egg cell ) production administration investigative drug , MK-8962 ( corifollitropin alfa ) + recombinant follicle stimulate hormone ( recFSH ) , contrast use reference drug , recFSH .</brief_summary>
	<brief_title>An Efficacy Safety Study Corifollitropin Alfa ( MK-8962 ) Contrast Recombinant FSH Use Controlled Ovarian Stimulation Indian Women ( P07056 , Also Known MK-8962-029 )</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Please Note : In trial Indian female participant define woman 1 ) native Indian parent , 2 ) also possession Indian identification card . Indian woman indication COS IVF/ICSI , yet undergone IVF/ICSI . Body mass index ( BMI ) 18.0 32.0 kg/m2 Regular spontaneous menstrual cycle ( ie , menstrual schedule consistently occur within range 24 35 day ) Access available ejaculatory sperm . Use donate and/or cryopreserved sperm allow , however sperm obtain via surgical sperm retrieval allow . Results document 'within normal limit ' clinical laboratory test ( ie , complete blood count [ CBC ] , blood chemistry , urinalysis ) . Normal cervical smear result obtain within 12 month prior study enrollment , otherwise test perform screen . Able adhere dose study visit schedule Has recent ( ie , within 3 year prior enrollment study ) history of/or active endocrine abnormality , treat untreated . Contraindicated use gonadotropins History ovarian hyperresponsiveness History of/or current polycystic ovary syndrome ( PCOS ) Has less 2 ovary ovarian abnormality , include endometrioma ( great 10 mm size ) , and/or unilateral bilateral hydrosalpinx and/or intrauterine fibroid ( 5 cm size great ) , confirm ultrasound scan . Has clinically relevant pathology may impair embryo implantation continuation pregnancy . Experienced three unsuccessful COS cycle IVF/ICSI since last establish ongoing pregnancy , applicable . History non low ovarian response FSH and/or Menopausal Gonadotropin ( hMG ) treatment . History recurrent miscarriage ( ie , 3 ) Positive test result Human Immunodeficiency Virus ( HIV ) Hepatitis B Recent history of/or current epilepsy , thrombophilia , diabetes , cardiovascular , gastrointestinal , hepatic , renal pulmonary autoimmune disease , require require treatment . Smokes recently stop smoking ( ie , within 3 month study enrollment ) History of/or active alcohol and/or drug abuse ( ie , within 12 month prior study enrollment ) . Previous use corifollitropin alfa Use hormonal agent know affect ovulation drug/agent consider teratogenic Use experimental drug within 3 month prior study enrollment participation another clinical study , one surveyquestionnaire base .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>